These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29358938)

  • 1. Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I Molecules.
    Moser SC; Voerman JSA; Buckley DL; Winter GE; Schliehe C
    Front Immunol; 2017; 8():1920. PubMed ID: 29358938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation.
    Palmer AL; de Jong A; Leestemaker Y; Geurink PP; Wijdeven RH; Ovaa H; Dolan BP
    J Immunol; 2018 Feb; 200(3):928-936. PubMed ID: 29282303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Interferons on Presentation of Defective Ribosomal Products as HLA Peptides.
    Komov L; Melamed Kadosh D; Barnea E; Admon A
    Mol Cell Proteomics; 2021; 20():100105. PubMed ID: 34087483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 Gag regulates its ubiquitination and MHC class I antigen presentation.
    Hahn S; Setz C; Wild J; Schubert U
    J Immunol; 2011 May; 186(10):5706-18. PubMed ID: 21482733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic pool.
    Fiebiger BM; Moosmann A; Behrends U; Mautner J
    Eur J Immunol; 2012 Dec; 42(12):3167-73. PubMed ID: 22944914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperone BAG6 is dispensable for MHC class I antigen processing and presentation.
    Bitzer A; Basler M; Groettrup M
    Mol Immunol; 2016 Jan; 69():99-105. PubMed ID: 26598275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific MHC-I Peptides Are Induced Using PROTACs.
    Jensen SM; Potts GK; Ready DB; Patterson MJ
    Front Immunol; 2018; 9():2697. PubMed ID: 30524438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral immune evasion: Lessons in MHC class I antigen presentation.
    van de Weijer ML; Luteijn RD; Wiertz EJ
    Semin Immunol; 2015 Mar; 27(2):125-37. PubMed ID: 25887630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.
    Strehl B; Seifert U; Krüger E; Heink S; Kuckelkorn U; Kloetzel PM
    Immunol Rev; 2005 Oct; 207():19-30. PubMed ID: 16181324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
    Udono H; Ichiyanagi T; Mizukami S; Imai T
    Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of cell proteins and the generation of MHC class I-presented peptides.
    Rock KL; Goldberg AL
    Annu Rev Immunol; 1999; 17():739-79. PubMed ID: 10358773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Processing of MHC class I presented antigens].
    van Endert P
    Med Sci (Paris); 2006; 22(8-9):727-32. PubMed ID: 16962047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
    Cho KJ; Walseng E; Ishido S; Roche PA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation.
    Grant EP; Michalek MT; Goldberg AL; Rock KL
    J Immunol; 1995 Oct; 155(8):3750-8. PubMed ID: 7561079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plumbing the sources of endogenous MHC class I peptide ligands.
    Yewdell JW
    Curr Opin Immunol; 2007 Feb; 19(1):79-86. PubMed ID: 17140786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies.
    Wolf BJ; Princiotta MF
    Mol Immunol; 2011 Jan; 48(4):463-71. PubMed ID: 21067810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
    Brazil MI; Weiss S; Stockinger B
    Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways of antigen processing and presentation.
    Watts C; Powis S
    Rev Immunogenet; 1999; 1(1):60-74. PubMed ID: 11256573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.